TY - CHAP
T1 - Drugs that act on the immune system
T2 - Immunosuppressive and immunostimulatory drugs
AU - Slobbe, Lennert
PY - 2012
Y1 - 2012
N2 - This review of the 2010 publications on immunosuppressive and immunostimulatory or immunoenhancing drugs covers ciclosporin, cyclophosphamide, everolimus, leflunomide, methotrexate, mizoribine, mycophenolate mofetil, sirolimus, tacrolimus, temsirolimus, the thiopurines, and the immunoenhancing drugs levamisole, picibanil, and thymosin α-1; there are also special reviews on fingolimod, glatiramer, gusperimus, imexon, and semapimod.
AB - This review of the 2010 publications on immunosuppressive and immunostimulatory or immunoenhancing drugs covers ciclosporin, cyclophosphamide, everolimus, leflunomide, methotrexate, mizoribine, mycophenolate mofetil, sirolimus, tacrolimus, temsirolimus, the thiopurines, and the immunoenhancing drugs levamisole, picibanil, and thymosin α-1; there are also special reviews on fingolimod, glatiramer, gusperimus, imexon, and semapimod.
UR - https://www.scopus.com/pages/publications/84872406517
U2 - 10.1016/B978-0-444-59499-0.00038-6
DO - 10.1016/B978-0-444-59499-0.00038-6
M3 - Chapter
AN - SCOPUS:84872406517
T3 - Side Effects of Drugs Annual
SP - 609
EP - 651
BT - A worldwide yearly survey of new data in adverse drug reactions and interactions
A2 - Aronson, J.K.
PB - Elsevier
ER -